Drug details
Belviq (lorcaserin hydrochloride)
type of
Belviq (lorcaserin hydrochloride) is a serotonin 2C receptor agonist indicated for the treatment of chronic weight management in adults with a body mass index (BMI) of 30 or greater (obese) as an addition to a reduced-calorie diet and exercise. Belviq is also approved for use by adults with a BMI of 27 or greater (overweight) and who have at least one weight-related condition such as high blood pressure (hypertension), type 2 diabetes, or high cholesterol (dyslipidemia).
This drug may have the following side effects:
- nausea,
- headache,
- dizziness,
- vomiting,
- diarrhea,
- cough,
- runny or stuffy nose,
- constipation,
- dry mouth,
- drowsiness,
- sore throat, or
- back pain,
- muscle pain,
- feeling tired,
- fatigue,
- urinary tract infection,
- upper respiratory tract infection,
- rash.
- low blood sugar (hypoglycemia),
- mental problems,
- slow heartbeat,
- painful erections,
The following drugs are related to Belviq, either as a replacement or used together:
- Adipex-P (phentermine hydrochloride)
- Alli (orlistat 60 mg)
- Belviq XR (lorcaserin hydrochloride extended release tablets)
- Didrex (benzphetamine)
- Contrave (naltrexone hcl and bupropion hcl extended-release tablets)
- Fastin (phentermine)
- Saxenda (liraglutide [rdna origin]) injection)
- Lomaira (phentermine hydrochloride tablets, usp)
- Meridia (sibutramine hydrochloride monohydrate)
- Xenical (orlistat 120 mg)
- Qsymia (phentermine and topiramate)
- Plenity (superabsorbent hydrogel particles in capsules)